Related references
Note: Only part of the references are listed.Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period
N. Kohei et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors
Matthias Kreuzaler et al.
JOURNAL OF IMMUNOLOGY (2012)
Phenotypic Evaluation of B-Cell Subsets After Rituximab for Treatment of Acute Renal Allograft Rejection in Pediatric Recipients
Valeriya Zarkhin et al.
TRANSPLANTATION (2011)
BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion
Mitchell Thorn et al.
CELLULAR IMMUNOLOGY (2010)
B cells and transplantation tolerance
Allan D. Kirk et al.
NATURE REVIEWS NEPHROLOGY (2010)
Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression
Madeleine V. Pahl et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells
A. Wölpl et al.
TISSUE ANTIGENS (2010)
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma
Stephen M. Ansell et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab
D. Bloom et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Stefanie Sarantopoulos et al.
BLOOD (2009)
B-cell-directed therapies for autoimmune disease
Thomas Doerner et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss
Mordi R. Muorah et al.
PEDIATRIC TRANSPLANTATION (2009)
BAFF May Modulate the Rate of B-Cell Repopulation After Rituximab Therapy for Acute Renal Transplant Rejection
Valeriya Zarkhin et al.
TRANSPLANTATION (2009)
Abnormal High Expression of B-Cell Activating Factor Belonging to the TNF Superfamily (BAFF) Associated With Long-Term Outcome in Kidney Transplant Recipients
H. Xu et al.
TRANSPLANTATION PROCEEDINGS (2009)
A Randomized, Prospective Trial of Rituximab for Acute Rejection in Pediatric Renal Transplantation
V. Zarkhin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome
Michael R. Pranzatelli et al.
CYTOKINE (2008)
Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: Does in vitro evidence translate to the clinical setting?
Ahmet Demirkiran et al.
TRANSPLANTATION (2008)
B cell survival in intragraft tertiary lymphoid organs after rituximab therapy
Olivier Thaunat et al.
TRANSPLANTATION (2008)
Chronic kidney disease stage in renal transplantation - classification using cystatin C and creatinine-based equations
Christine White et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
The role of the BAFF/APRIL system on T cell function
Fabienne Mackay et al.
SEMINARS IN IMMUNOLOGY (2006)
Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab
A Lehnhardt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
Therese Vallerskog et al.
ARTHRITIS RESEARCH & THERAPY (2006)
BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders
SJ Rodig et al.
HUMAN PATHOLOGY (2005)
B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells
LG Ng et al.
JOURNAL OF IMMUNOLOGY (2004)
Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?
G Filler et al.
PEDIATRIC NEPHROLOGY (2003)
Lymphocyte subsets in healthy children from birth through 18 years of age: The pediatric AIDS clinical trials group P1009 study
WT Shearer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
BAFF: A fundamental survival factor for B cells
F Mackay et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Share Paper
